ADALIMUMAB (ADA) AND INFLIXIMAB (IFX) THERAPY DURING PREGNANCY IN IBD: A PROSPECTIVE ASSESSMENT OF OUTCOME, SAFETY AND CORD BLOOD LEVELS.
(1) Medical University Vienna
This item was part of the IBD II session at 20th United European Gastroenterology Week
This item can be cited as: Gut 2012; 61 (Suppl 3) A287
You may be interested in:
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
English, Abstract, 2012